Back to News

Biotech Outsourcing Strategies (BOS) 2021, Virtual

Biotech Outsourcing Strategies (BOS) is an established outsourcing focused conference and exhibition for the international Pharmaceutical industry. The event scope is focused on Discovery outsourcing and CMC outsourcing for both small molecules and biologics (primarily development stage). Catherine Cancian, VP Pharmaceutical Operations, GenSight Biologics, will give an oral presentation on Day 3.
  • Title: Designing a Robust CMC Outsourcing Strategy for a Gene Therapy Product and Adapting to Business Interruption Presented by Covid-19
  • Day 3 – Biologics CMC Outsourcing Focus
  • Session: Outsourcing Perspectives – CMC Biologics Focus
  • Date and time: 1st July 2021 – 10:00 – 10:20 (BST)
Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France